Skip to main content
Top
Published in: Clinical Rheumatology 2/2012

01-02-2012 | Original Article

Portuguese version of the bath indexes for ankylosing spondylitis patients: a cross-cultural adaptation and validation

Authors: F. M. Pimentel-Santos, T. Pinto, H. Santos, A. Barcelos, I. Cunha, J. C. Branco, P. L. Ferreira

Published in: Clinical Rheumatology | Issue 2/2012

Login to get access

Abstract

The Bath Ankylosing Spondylitis Activity Index (BASDAI), Functional Index (BASFI), Metrology Index (BASMI), and Global Score (BASG) are commonly used to assess patients with ankylosing spondylitis (AS). The aim of this study was to cross-culturally adapt and validate these indexes into the Portuguese language. Seventy-eight patients were included in the study. After forward and backward translations, the questionnaires were administered and tested for internal consistency, test–retest reliability, face validity, content validity, and construct validity. The outcome measures HAQ, EQ-5D, and SF-36 were also implemented. Metrological parameters (BASMI components) and chest expansion were evaluated. Correlation coefficients for test–retest were 0.875, 0.937, 0.831, and 0.961 for BASDAI, BASFI, BASMI, and BASG, respectively. Internal consistency coefficients were between 0.747 and 0.953. The adapted and translated questionnaires demonstrated an acceptable comprehensibility by a panel of patients, and face validity was assured by the cognitive debriefing performed. Content validity was assured by comparing the scores obtained by the questionnaires when age and gender, age of symptoms onset, and disease duration were considered. Construct validity was assured by significant correlations established between the Bath scores and generic health status HAQ, EQ-5D and SF-36, morning stiffness duration, chest expansion, and physician disease activity assessment. The Portuguese version of the BASDAI, BASFI, BASG, and BASMI showed adequate reliability and validity in patients with AS. The measurement properties were comparable to versions in other languages, indicating that the indexes can be used for evaluation of Portuguese-speaking AS patients.
Literature
1.
go back to reference Boonen A, Braun J, van der Horst Bruinsma IE, Huang F, Maksymowych W, Kostanjsek N, Cieza A, Stucki G, van der Heijde D (2010) ASAS/WHO ICF core sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health. Ann Rheum Dis 69:102–107PubMedCrossRef Boonen A, Braun J, van der Horst Bruinsma IE, Huang F, Maksymowych W, Kostanjsek N, Cieza A, Stucki G, van der Heijde D (2010) ASAS/WHO ICF core sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health. Ann Rheum Dis 69:102–107PubMedCrossRef
2.
go back to reference Garret S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286–2291 Garret S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286–2291
3.
go back to reference Calin A, Garret S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed Calin A, Garret S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed
4.
go back to reference Jones SD, Steiner A, Garrett S, Calin A (1996) The Bath Ankylosing Spondylitis Patient Global score (BAS-G). British J Rheumatol 35:66–71CrossRef Jones SD, Steiner A, Garrett S, Calin A (1996) The Bath Ankylosing Spondylitis Patient Global score (BAS-G). British J Rheumatol 35:66–71CrossRef
5.
go back to reference Jenkinson T, Mallorie P, Whitelock H, Kennedy LG, Garret S, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrological Index. J Rheumatol 21:1694–1698PubMed Jenkinson T, Mallorie P, Whitelock H, Kennedy LG, Garret S, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrological Index. J Rheumatol 21:1694–1698PubMed
6.
go back to reference Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46:1417–1432PubMedCrossRef Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46:1417–1432PubMedCrossRef
7.
go back to reference van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. ArthritisRheum 27:361–368CrossRef van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. ArthritisRheum 27:361–368CrossRef
8.
go back to reference Santos RA, Reis P, Rebelo L, Dias FC, Rosa C, Queirós MV (1986) Health Assessment Qustionnaire (versão curta): adaptação para língua portuguesa e estudo da sua aplicabilidade. Acta Reum Port 76:15–20 Santos RA, Reis P, Rebelo L, Dias FC, Rosa C, Queirós MV (1986) Health Assessment Qustionnaire (versão curta): adaptação para língua portuguesa e estudo da sua aplicabilidade. Acta Reum Port 76:15–20
9.
go back to reference Ferreira PL, Criação da versão portuguesa do MOS SF-36 (2000) Parte I–adaptação cultural e linguistica. Acta Med Port 13(1–2):55–66PubMed Ferreira PL, Criação da versão portuguesa do MOS SF-36 (2000) Parte I–adaptação cultural e linguistica. Acta Med Port 13(1–2):55–66PubMed
10.
go back to reference Ferreira PL, Criação da versão portuguesa do MOS SF-36 (2000) Parte II–testes de validação. Acta Med Port 13(3):119–127PubMed Ferreira PL, Criação da versão portuguesa do MOS SF-36 (2000) Parte II–testes de validação. Acta Med Port 13(3):119–127PubMed
11.
go back to reference Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J et al (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60:34–42PubMedCrossRef Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J et al (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60:34–42PubMedCrossRef
12.
go back to reference Fermanian J (1984) Measuring agreement between 2 observers: a quantitative case. Rev Epidemiol Sante Publique 32:408–413PubMed Fermanian J (1984) Measuring agreement between 2 observers: a quantitative case. Rev Epidemiol Sante Publique 32:408–413PubMed
13.
go back to reference Ruof J, Sangha O, Stucki G (1999) Evaluation of a German version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Dougados Functional Index (D-FI). Z Rheumatol 58:218–225PubMedCrossRef Ruof J, Sangha O, Stucki G (1999) Evaluation of a German version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Dougados Functional Index (D-FI). Z Rheumatol 58:218–225PubMedCrossRef
14.
go back to reference Heikkila S, Viitanen JV, Kautianen H, Kauppi M (2000) Evaluation of the Finnish versions of the functional indices BASFI and DFI in spondylarthropathy. Clin Rheumatol 19:464–469PubMedCrossRef Heikkila S, Viitanen JV, Kautianen H, Kauppi M (2000) Evaluation of the Finnish versions of the functional indices BASFI and DFI in spondylarthropathy. Clin Rheumatol 19:464–469PubMedCrossRef
15.
go back to reference Cardiel MH, Londono JD, Gutierrez E, Pacheco-Tena C, Vázquez-Mellado J, Burgos-Vargas R (2003) Translation, crosscultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies. Clin Exp Rheumatol 21:451–458PubMed Cardiel MH, Londono JD, Gutierrez E, Pacheco-Tena C, Vázquez-Mellado J, Burgos-Vargas R (2003) Translation, crosscultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies. Clin Exp Rheumatol 21:451–458PubMed
16.
go back to reference Salaffi F, Stancati A, Silvestri A, Carotti M, Grassi W (2005) Validation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis. Reumatismo 57:161–173PubMed Salaffi F, Stancati A, Silvestri A, Carotti M, Grassi W (2005) Validation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis. Reumatismo 57:161–173PubMed
17.
go back to reference Pedersen OB, Hansen GO, Svendsen AJ, Ejstrup L, Junker P (2007) Adaptation of the Bath measures on disease activity and function in ankylosing spondylitis into Danish. Scand J Rheumatol 36:22–27PubMedCrossRef Pedersen OB, Hansen GO, Svendsen AJ, Ejstrup L, Junker P (2007) Adaptation of the Bath measures on disease activity and function in ankylosing spondylitis into Danish. Scand J Rheumatol 36:22–27PubMedCrossRef
18.
go back to reference El Miedany Y, Youssef S, Mehanna A, Shebrya N, Abu Gamra S, El GM (2008) Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Global Score (BASG). Clin Rheumatol 27:605–612PubMedCrossRef El Miedany Y, Youssef S, Mehanna A, Shebrya N, Abu Gamra S, El GM (2008) Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Global Score (BASG). Clin Rheumatol 27:605–612PubMedCrossRef
19.
go back to reference Lin Z, Gu J, He P, Gao J, Zuo X, Ye Z, Shao F, Zhan F, Lin J, Li L, Wei Y, Xu M, Liao Z, Lin Q (2011) Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients. Rheumatol Int 31:233–238PubMedCrossRef Lin Z, Gu J, He P, Gao J, Zuo X, Ye Z, Shao F, Zhan F, Lin J, Li L, Wei Y, Xu M, Liao Z, Lin Q (2011) Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients. Rheumatol Int 31:233–238PubMedCrossRef
20.
go back to reference Shinjo SK, Gonçalves R, Kowalski S, Gonçalves CR (2007) Brazilian–Portuguese version and applicability questionnaire of the mobility index for ankylosing spondylitis. Clinics 62(2):139–144PubMedCrossRef Shinjo SK, Gonçalves R, Kowalski S, Gonçalves CR (2007) Brazilian–Portuguese version and applicability questionnaire of the mobility index for ankylosing spondylitis. Clinics 62(2):139–144PubMedCrossRef
Metadata
Title
Portuguese version of the bath indexes for ankylosing spondylitis patients: a cross-cultural adaptation and validation
Authors
F. M. Pimentel-Santos
T. Pinto
H. Santos
A. Barcelos
I. Cunha
J. C. Branco
P. L. Ferreira
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2012
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1864-5

Other articles of this Issue 2/2012

Clinical Rheumatology 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine